Skip to content

Study · Not a test of the peptide alone · 2004

3 results

Study on Fmoc solid--phase synthesis and activity of thymosin #alpha#_(1)

Han Xiang, Gu Jun, Yuan Qinglan, Gan Yiru

Chinese Journal of Medicinal Chemistry1 Jan 2004

PepBankPUB-96358914
Ask about this study
Jump to 3 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse.

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone3

In this study, Thymosin alpha-1 was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymosin alpha-1.

  1. 01LabNot a test of Thymosin alpha-1 aloneOther designOther

    Fmoc solid-phase total synthesis of thymosin alpha‑1 gave a yield of 33.2%.

    In plain wordsIn a chemistry method, thymosin alpha‑1 was made with a yield of 33.2%.

    Peptide
    Thymosin alpha-1
    Outcome
    Not applicableSynthesis yield
    Study

    n: not reported in source

    Outcome group
    Synthesis and manufacturing · Pharmacology

    Measurements

    Yield
    33.2%
    Fmoc solid-phase synthesis

    Source sentences

    Summary
    The yield of the total synthesis was 33.2%, based on the amino acid content of the starting Fmoc-Asn(Trt)-resin.

    In this study, Thymosin alpha-1 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin alpha-1.

  2. 02LabNot a test of Thymosin alpha-1 aloneOther designOther

    The synthetic thymosin alpha‑1 had a purity above 98.8%.

    In plain wordsIn a chemistry method, the made thymosin alpha‑1 was more than 98.8% pure.

    Peptide
    Thymosin alpha-1
    Outcome
    Not applicablePurity of synthetic product
    Study

    n: not reported in source

    Outcome group
    Synthesis and manufacturing · Pharmacology

    Measurements

    Purity
    > 98.8%
    synthetic thymosin alpha 1

    Source sentences

    Summary
    The purity was range to above 98.8%

    In this study, Thymosin alpha-1 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin alpha-1.

  3. 03LabNot a test of Thymosin alpha-1 aloneOther designActivity measurement

    The activity of synthetic thymosin alpha‑1 was equal to that of Zadaxin.

    In plain wordsIn a lab check, the made thymosin alpha‑1 was as active as Zadaxin.

    Peptide
    Thymosin alpha-1
    Outcome
    No significant changeActivity of synthetic product compared with Zadaxin
    Study

    n: not reported in source

    Comparator
    Zadaxin
    Outcome group
    Synthesis and manufacturing · Pharmacology

    Source sentences

    Summary
    the activity is equal to that of Zadaxin.

    In this study, Thymosin alpha-1 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin alpha-1.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    12 Oct 2026, 17:28 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 03:02 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.